BioCentury | Jun 13, 2016
Finance

Venture double-double

...background knowledge of the pharma organization. We also have the ability to reach into our Millipore...
BioCentury | Nov 16, 2015
Company News

Merck KGaA, Turgut Ilac deal

...Merck’s Merck Millipore business will provide its Provantage End-to-End services for the development and manufacturing of...
...biosimilar pipeline, beginning with biosimilars for non-small cell lung cancer (NSCLC) and rheumatoid arthritis (RA). Millipore...
BioCentury | Sep 23, 2014
Top Story

Merck buying Sigma-Aldrich for $17B

...posted revenues of $2.7 billion in 2013. Merck said the acquisition would complement its EMD Millipore...
BioCentury | Mar 31, 2014
Company News

Merck KGaA management update

...of R&D in the interim Promoted: Udit Batra to president and CEO of Merck's EMD Millipore...
BioCentury | Mar 26, 2014
Company News

Jenkins leaving Merck Serono

...of the pharma's consumer health division, was promoted to president and CEO of Merck's EMD Millipore...
BioCentury | Mar 24, 2014
Company News

Sysmex, Merck KGaA deal

...Merck's EMD Millipore division and Sysmex partnered to jointly develop EMD Millipore's Amnis imaging flow cytometry...
BioCentury | Mar 17, 2014
Company News

Massachusetts Life Sciences Center (MLSC) pharmaceuticals news

...develop a production platform for viral vectors with improved digestion of DNA impurities. The EMD Millipore Corp....
...develop a product with a "human liver like" phenotype for early stage toxicity testing. EMD Millipore...
BioCentury | Mar 10, 2014
Company News

J&J management update

...The Carlyle Group acquires the business, expected in mid-2014, formerly president, CEO and chairman of Millipore Corp....
BioCentury | Sep 24, 2012
Company News

Merck KGaA, Kyoto University deal

...Merck's EMD Millipore Corp. division received a non-exclusive, worldwide license to develop and commercialize an induced pluripotent...
...portfolio for research applications from the university's technology transfer arm, iPS Academia Japan Inc. EMD Millipore...
BioCentury | Aug 20, 2012
Company News

Ark Therapeutics, Merck KGaA deal

...Ark Therapeutics and Merck's EMD Millipore Corp. division signed a non-binding letter of intent to partner for...
...manufacturing facility. The partners also plan to establish a suite at the facility with EMD Millipore's...
Items per page:
1 - 10 of 104
BioCentury | Jun 13, 2016
Finance

Venture double-double

...background knowledge of the pharma organization. We also have the ability to reach into our Millipore...
BioCentury | Nov 16, 2015
Company News

Merck KGaA, Turgut Ilac deal

...Merck’s Merck Millipore business will provide its Provantage End-to-End services for the development and manufacturing of...
...biosimilar pipeline, beginning with biosimilars for non-small cell lung cancer (NSCLC) and rheumatoid arthritis (RA). Millipore...
BioCentury | Sep 23, 2014
Top Story

Merck buying Sigma-Aldrich for $17B

...posted revenues of $2.7 billion in 2013. Merck said the acquisition would complement its EMD Millipore...
BioCentury | Mar 31, 2014
Company News

Merck KGaA management update

...of R&D in the interim Promoted: Udit Batra to president and CEO of Merck's EMD Millipore...
BioCentury | Mar 26, 2014
Company News

Jenkins leaving Merck Serono

...of the pharma's consumer health division, was promoted to president and CEO of Merck's EMD Millipore...
BioCentury | Mar 24, 2014
Company News

Sysmex, Merck KGaA deal

...Merck's EMD Millipore division and Sysmex partnered to jointly develop EMD Millipore's Amnis imaging flow cytometry...
BioCentury | Mar 17, 2014
Company News

Massachusetts Life Sciences Center (MLSC) pharmaceuticals news

...develop a production platform for viral vectors with improved digestion of DNA impurities. The EMD Millipore Corp....
...develop a product with a "human liver like" phenotype for early stage toxicity testing. EMD Millipore...
BioCentury | Mar 10, 2014
Company News

J&J management update

...The Carlyle Group acquires the business, expected in mid-2014, formerly president, CEO and chairman of Millipore Corp....
BioCentury | Sep 24, 2012
Company News

Merck KGaA, Kyoto University deal

...Merck's EMD Millipore Corp. division received a non-exclusive, worldwide license to develop and commercialize an induced pluripotent...
...portfolio for research applications from the university's technology transfer arm, iPS Academia Japan Inc. EMD Millipore...
BioCentury | Aug 20, 2012
Company News

Ark Therapeutics, Merck KGaA deal

...Ark Therapeutics and Merck's EMD Millipore Corp. division signed a non-binding letter of intent to partner for...
...manufacturing facility. The partners also plan to establish a suite at the facility with EMD Millipore's...
Items per page:
1 - 10 of 104